Study of the Predictive and Prognostic Role of Pharmacogenetic and Radiogenic Variants on the Response to Neoadjuvant Chemoradiation Therapy in Patients With Locally Advanced Rectal Cancer
Not yet recruitingOBSERVATIONAL
Enrollment
460
Participants
Timeline
Start Date
October 3, 2024
Primary Completion Date
October 3, 2029
Study Completion Date
October 3, 2029
Conditions
Rectal Cancer
Trial Locations (1)
33081
Centro di Riferimento Oncologico (CRO) di Aviano - IRCCS, Aviano